Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study
Contemporary Clinical Trials · 2023
DOI: 10.1016/j.cct.2023.107273 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Contemporary Clinical Trials, 2023. Verfasst von Stacey A Cohen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Division, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, Seattle, WA 98109, USA; Division of Medical Oncology, University of Wa…. Hauptthemen laut MEDLINE: Acupressure, Pancreatic Neoplasms, Antineoplastic Agents, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS, National Center for Complementary and Integrative Health.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Oxaliplatin is a key chemotherapeutic agent in the treatment of local and metastatic gastrointestinal (GI) malignancies. Dose density and treatment adherence can be limited by chemotherapy-induced peripheral neuropathy (CIPN). Early research suggests CIPN incidence and severity may be mitigated by acupuncture, but rigorous data in GI oncology patients is limited. Here, we describe the protocol of a randomized, waitlist-controlled pilot study testing the use of preemptive of acupuncture plus acupressure to decrease CIPN and chemotherapy-related toxicities. METHODS: Patients with a GI malignancy (n = 56) with planned 5-fluorouracil (5-FU) and oxaliplatin IV (FOLFOX, FOLFIRINOX) every 2 weeks are being recruited. Additional concurrent anti-neoplastic agents may be used. Enrolled patients are randomized 1:1 to a 3-month intervention of Arm A: acupuncture with acupressure and standard-of-care treatment, or Arm B: standard-of-care alone. In Arm A, on days 1 and 3 of each chemotherapy cycle a standardized acupuncture protocol is administered and patients are taught self-acupressure to perform daily between chemotherapy treatments. Patients in both arms are given standard-of-care oral and peripheral (hands/feet) ice chip cryotherapy during oxaliplatin administration. CIPN and other symptoms are assessed at baseline, 6 weeks, and 3 months from registration. The primary endpoint is CIPN severity at 3 months (EORTC-CIPN 20). Additional endpoints evaluate CIPN incidence (CTCAE, Neuropen, tuning fork); incidence of pain, fatigue, nausea, oral dysesthesia, and anxiety; and feasibility (recruitment, retention, adherence, acceptability). If warranted, trial results will inform the design of a multi-center trial to expand testing of the intervention to a larger patient cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Division, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, Seattle, WA 98109, USA; Division of Medical Oncology, University of Washington School of Medicine, USA. Electronic address: shiovitz@uw.edu.
- Integrative Medicine Program, Division of Supportive Care, Fred Hutchinson Cancer Center, USA; Division of Public Health Sciences, Fred Hutchinson Cancer Center, USA.
- Division of Public Health Sciences, Fred Hutchinson Cancer Center, USA.
- Clinical Research Division, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, Seattle, WA 98109, USA.
- Clinical Research Division, Fred Hutchinson Cancer Center, 825 Eastlake Ave E, Seattle, WA 98109, USA; Division of Medical Oncology, University of Washington School of Medicine, USA.
- Integrative Medicine Program, Division of Supportive Care, Fred Hutchinson Cancer Center, USA.
Förderung
- NCCIH NIH HHS
- National Center for Complementary and Integrative Health
Zitieren
APA
Cohen, S. A., Veleber, S., Siman, J., Guthrie, K. A., McMillen, K., Heit, M., Wadhera, S., Daniels, J., Hansen, K., Jacoby, M., Taromina, K., Chin, S., Romeo, M., Langley, B. O., Coveler, A. L., Hannan, L. M., King, G., Purcell, T., Safyan, R. A., …, & Greenlee, H. (2023). Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study. Contemporary Clinical Trials. https://doi.org/10.1016/j.cct.2023.107273
Vancouver
Cohen SA, Veleber S, Siman J, Guthrie KA, McMillen K, Heit M, et al. Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study. Contemporary Clinical Trials. 2023. doi:10.1016/j.cct.2023.107273
BibTeX
@article{Cohen2023,
author = {Cohen, Stacey A and Veleber, Susan and Siman, Jonathan and Guthrie, Katherine A and McMillen, Kerry and Heit, Madilyn and Wadhera, Sonia and Daniels, Jonathan and Hansen, Kjell and Jacoby, Madeline and Taromina, Katherine and Chin, Samantha and Romeo, Melissa and Langley, Blake O and Coveler, Andrew L and Hannan, Lindsay M and King, Gentry and Purcell, Tom and Safyan, Rachael A and Shankaran, Veena and Zhen, David B and Chiorean, E Gabriela and Greenlee, Heather},
title = {Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study},
journal = {Contemporary Clinical Trials},
year = {2023},
doi = {10.1016/j.cct.2023.107273}
}
EUVIMED